📰 Conversion Labs News
Conversion Labs News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Conversion Labs. Real-time updates on events, politics, business and more.
May 20, 2024
Pono Capital Two (NASDAQ:PTWO – Get Free Report) and LifeMD (NASDAQ:LFMD – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk. Insider & Institutional Ownership 60.8% of Pono […]
May 20, 2024
LifeMD (NASDAQ:LFMD – Get Free Report) and Pono Capital Two (NASDAQ:PTWO – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, institutional ownership, valuation, earnings and analyst recommendations. Profitability This table compares LifeMD and Pono […]
May 2, 2024
LifeMD (NASDAQ:LFMD – Get Free Report) and Pono Capital Two (NASDAQ:PTWO – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations and institutional ownership. Analyst Recommendations This is a summary of […]
May 2, 2024
Pono Capital Two (NASDAQ:PTWO – Get Free Report) and LifeMD (NASDAQ:LFMD – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations and institutional ownership. Analyst Ratings This is a summary of […]
November 23, 2023
Phreesia (NYSE:PHR – Get Free Report) and LifeMD (NASDAQ:LFMDP – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings. Institutional and Insider Ownership 94.4% of Phreesia shares are owned […]
October 15, 2023
ETAO International (NASDAQ:ETAO – Get Free Report) and LifeMD (NASDAQ:LFMD – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability and institutional ownership. Profitability This table compares ETAO International and LifeMD’s […]
September 12, 2023
Vitalhub (OTCMKTS:VHIBF – Get Free Report) and LifeMD (NASDAQ:LFMD – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership. Institutional and Insider Ownership 17.6% of LifeMD shares are held […]
September 12, 2023
Vitalhub (OTCMKTS:VHIBF – Get Free Report) and LifeMD (NASDAQ:LFMD – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, dividends and profitability. Insider & Institutional Ownership 17.6% of LifeMD shares are owned […]
August 19, 2023
JE Cleantech (NASDAQ:JCSE – Get Free Report) and Conversion Labs (OTCMKTS:CVLBD – Get Free Report) are both small-cap industrial products companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, institutional ownership, dividends and analyst recommendations. Analyst Ratings This is a summary […]
February 16, 2023
Conversion Labs (OTCMKTS:CVLBD – Get Rating) is one of 30 public companies in the “Miscellaneous Manufacturing Industries” industry, but how does it weigh in compared to its competitors? We will compare Conversion Labs to similar businesses based on the strength of its valuation, institutional ownership, profitability, dividends, risk, analyst recommendations and earnings. Analyst Recommendations This […]